ACADIA Pharmaceuticals Inc
SWB:DR6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
ACADIA Pharmaceuticals Inc
SWB:DR6
|
US |
|
S
|
Singapore Technologies Engineering Ltd
F:SJX
|
SG |
|
V
|
Vita 34 AG
XMUN:V3V
|
DE |
|
P
|
Persimmon PLC
F:OHP
|
UK |
|
H
|
Healthcare Services Group Inc
F:HS1
|
US |
|
V
|
Venture Global Inc
NYSE:VG
|
US |
|
I
|
IHI Corp
F:IWJ
|
JP |
|
Yamada Holdings Co Ltd
TSE:9831
|
JP |
|
G
|
Greatland Gold PLC
OTC:GRLGF
|
UK |
|
Vow ASA
OTC:SSHPF
|
NO |
|
Gold Fields Ltd
F:EDG
|
ZA |
|
R
|
Ritchie Bros Auctioneers Inc
F:2R8
|
CA |
|
DS Smith PLC
OTC:DSSMY
|
UK |
|
B
|
BT Group PLC
F:BTQ
|
UK |
|
S
|
Slater & Gordon Ltd
XBER:OQH
|
AU |
|
L
|
Legible Inc
CNSX:READ
|
CA |
|
Euronet Worldwide Inc
NASDAQ:EEFT
|
US |
|
C
|
Capacite Infraprojects Ltd
NSE:CAPACITE
|
IN |
|
Darktrace PLC
OTC:DRKTF
|
UK |
|
KBC Groep NV
OTC:KBCSY
|
BE |
|
A
|
Ageas SA
XHAM:FO4N
|
BE |
Bankruptcy Probability
ACADIA Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ACADIA Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
4.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
197.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ACADIA Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ACADIA Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
